Soleno Therapeutics earnings were -$175.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SLNO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$56.0M, down 26.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLNO reported annual earnings of -$175.9M, with 351% growth. The next SLNO earnings date is Jun 6, 2025.
Soleno Therapeutics Earnings Reports & History FAQ
What were Soleno Therapeutics's earnings last quarter?
On SLNO's earnings call on Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q4 2024 earnings per share (EPS) of -$1.30, up 548.28% year over year. Total SLNO earnings for the quarter were -$55.98 million. In the same quarter last year, Soleno Therapeutics's earnings per share (EPS) was $0.29.
The next SLNO earnings date is Invalid Date. Add SLNO to your watchlist to be reminded of Soleno Therapeutics's next earnings date.
What was SLNO's earnings growth in the past year?
As of Soleno Therapeutics's earnings date in Invalid Date, Soleno Therapeutics's earnings has grown year over year. SLNO earnings in the past year totalled -$175.85 million.
Is Soleno Therapeutics profitable or losing money?
As of the last Soleno Therapeutics earnings report, Soleno Therapeutics is currently losing money. Soleno Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$175.85 million, a 351.04% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.